A 68-year-old man with chronic use of an ocular prosthesis for phthisis bulbi of his left eye due to ocular trauma 25 years ago was referred to our ophthalmic department with a 6-month history of repetitive upper eyelid abscess with poor response to treatment.
Introduction
Squamous cell carcinoma (SCCA) of the conjunctiva is an uncommon tumor that arise de novo or from a prior conjunctival or corneal intraepithelial neoplasm [1] . A typical presentation is a slowgrowing mass involving the limbus in the elderly with a complaint of ocular irritation or redness [2] .
Various risk factors for conjunctival SCCA have been identified, including excessive exposure to ultraviolet radiation, infection with human papilloma virus (HPV) types 16 and 18, and human immunodeficiency virus (HIV) [3] .
SCCA of the conjunctiva has also been described in association with chronic ocular inflammatory diseases, such as benign mucous membrane pemphigoid, chronic blepharoconjunctivitis, and atopic eczema [3] .
Conjunctival SCCA arising in the anophthalmic socket is uncommon; with few reports existing within the literature [3] . The majority of these few cases presented with invasive disease and was treated with orbital exenteration.
We present a case of conjunctival basaloid squamous cell carcinoma, developing in patient with phthisis bulbi and chronic use of an ocular prosthesis, treated with orbital exenteration and radiotherapy.
Consent to use identifiable photographs was signed by the patient and it is filed by authors.
Background
To describe a case of squamous cell carcinoma of the conjunctiva developed 20 years after ocular trauma that was the cause of phthisis bulbi and chronic use of an ocular prosthesis.
Case Report
A 68-year-old man, who developed phthisis bulbi of his left eye at the age of 42 after ocular trauma, was referred to our ophthalmic department by his general practitioner with a history of repetitive upper eyelid abscess with poor response to various treatments with antibiotics. The patient referred that his symptoms started after having a new prosthesis made 6 months ago.
The patient had worn and renewed his ocular prosthesis regularly during the last 25 years without any significant discomfort.
Aside from the phthisis bulbi, the patient had an unremarkable past medical history. He did not use tobacco and reported that he had no history of chemical or excessive sun exposure.
The ocular examination was significant for upper and lower eyelid edema with erythema, thickening and induration mainly in the medial canthus and friable conjunctival tissue of eye socket with tendency to bleed. No areas suspicious for malignancy were noted.
There was no palpable preauricular or submandibular lymphadenopathy. The initial orbital CT scan showed an inflammatory collection in palpebral and interpalpebral areas with orbit infiltration.
An initial surgical biopsy was taken of the conjunctival tissue. Histopathological examination showed islands of conjunctival basaloid squamous cell carcinoma.
MRI of the orbit with gadolinium revealed an enhancing preseptal orbital mass with dimensions of 3.8 cm x 3.7 cm x 2.6 cm with involvement of both eyelids and invasion of the retroseptal medial The lesion reached the medial rectus muscle and superior oblique muscle and caused a lateral displacement of the optic nerve. A baseline work-up for systemic disease, including a complete blood cell 
count, chemistry panel, liver enzymes panel, and imaging of the chest, abdomen, and pelvis, was negative. Even the otorhinolaryngological exploration was free of lesion macroscopically.
Two weeks later the patient underwent an ocular and orbital exenteration with excision of the skin and conjunctival tumors under frozen section control. Histopathology revealed poorly differentiated conjunctival basaloid squamous cell carcinoma with lesion free margins except for a remaining microscopic contact with the lesion in the medial margin. The remaining eye tissue that was removed and analyzed was free of lesion.
The reconstruction process involved a rotation flap of the left temporal muscle with cervicofacial advancement (Figure 1 
Discussion
Conjunctival SCCA in anophthalmic sockets is quite rare. Few reports of conjunctival SCCA that has developed in an anophthalmic socket exist within the literature [3] . In a recent review on this subject by Vargason et al. a total of ten cases of anophthalmic socket SCC have been summarized, we will mention some of them as examples [4] ; Campanella et al. first reported 2 cases of this tumor in 1998 [5] . Chaudhry et al. in 2006 described a growing mass in a patient´s left orbit, the eye having been enucleated 50 years ago [6] . In 2011, Espana et al. described a 62-year-old man presenting 60 years after enucleation with a recurrent lesion after benign papilloma excision 2 years prior [7] .
In each of the previously reported cases, prosthesis was worn for at least 40 years [3, [6] [7] [8] [9] , except for 1 case that developed an in-situ SCC after 32 years of wearing the original prosthesis without routine maintenance [4] .
In our report, we have described a case of conjunctival SCCA that developed after 25 years of long-term use of ocular prosthesis. Ourpatient had primary involvement of both the bulbar and palpebral conjunctiva with extension in the deep orbital tissues and sparing of the eyelid skin.
Although excessive sun exposure could be a risk factor for developing conjunctival SCCA in general, it was not suspected as one in any of the above-mentioned cases. Other risk factors such as local HPV infection or systemic immunodeficiency disease did not clearly contribute to these cases. Nevertheless, we must mention that in the case described by Gaier et al., the surgically resected SCCA tissue was positive for human papilloma virus serotype [16] .
Chronic irritation was speculated as the main contributing factor to the tumor development in these cases. Some of the patients had complained about an ill-fitting prosthesis for a long time [11] .
Kim et alreported that although the conjunctiva in the anophthalmic sockets showed squamous metaplasia, there was no correlation between the particular aspects of prosthesis care, including total wearing time and frequency of polishing, and cytologic features of the conjunctival epithelium [12] . In our case, the patient didn't have a poor fitting prosthesis, no ultraviolet exposure of the conjunctival surface, which was covered by the ocular prosthesis,and he did not have any of the other known risk factors for SCCA, such as HIV infection. Therefore, and presuming that prosthesis care has not been related to carcinogenesis, the hypothesis remaining is that chronic irritation or microtrauma between the upper conjunctiva and the prosthesis could be the main trigger for developing SCCA because continuous friction of the prosthesis could easily create these conditions through the daily movement of the upper eyelid.
Others who reported conjunctival SCCA of anophthalmic socket have hypothesized that chronic conjunctival inflammation due to prosthesis use may predispose patients to dysplastic changes, which over time may slowly transform into invasive SCCA [6, 8, 9] .
The relationship between inflammation and cancer is complex. In 1863 Virchow described a lymphoreticular infiltrate within cancer tissue, leading to the hypothesis that cancer arose from sites of chronic inflammation [13] .
Once a lesion is detected, several treatment modalities, including surgical excision, cryotherapy, radiation, and a variety of topically applied chemotherapeutic agents exist, including mitomycin C [14] .
All the previously reported cases of invasive SCCA in anophthalmic sockets were treated with orbital exenterationwith or without subsequent radiation. The exception was in the in-situ case of Barrett et al. [4] which was treated with excision under frozen section control and reconstruction via a Mustarde flap, hard palategraft, and fornix deepening sutures.
In our case, ocular and orbital exenteration was performed including the upper and lower conjunctiva with total resection of the upper and lower eyelid skin. For the reconstruction of the defect, we chose to use a rotation flap of the left temporal muscle with cervicofacial flap advancement because both the upper and lower eyelid skin were included in the resection. We planned subsequent radiation therapy.
Conclusion
Conjunctival SCCA that arises from a chronic use of ocular prosthesis is quite rare; however, unlike regular conjunctival SCCA, chronic irritation or microtrauma between upper conjunctiva and prosthesis has been suspected to be the main trigger for the development of this disease.
Our case report adds another example of this rare clinical finding to the literature and adds emphasis that clinicians should be aware of this possible long-term tumor.
